Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: A prospective nonrandomized study

American Journal of Obstetrics and Gynecology

Volumn 192, Issue 5 SPEC. ISS., 2005, Pages 1735-1740

  Werner, Matthias ^a   Schmid, Daniel Max ^b   Schüssler, Bernhard ^a  

^a LUZERNER KANTONSSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Botulinum toxin A; Detrusor overactivity incontinence; King's Health Questionnaire

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

AGED; ARTICLE; BLADDER DISEASE; CLINICAL TRIAL; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; QUALITY OF LIFE; RETREATMENT; TREATMENT OUTCOME; URINE INCONTINENCE; URODYNAMICS;

AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MIDDLE AGED; NEUROMUSCULAR AGENTS; QUALITY OF LIFE; RETREATMENT; TREATMENT OUTCOME; URINARY BLADDER DISEASES; URINARY INCONTINENCE; URODYNAMICS;

EID: 20644447123     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.11.052     Document Type: Article

References (15)

1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn 2002;21:167-78. (Pubitemid 34195211)
2. Hannestad YS, Rortveit G, Sandvik H, Hunskaar S. A communitybased epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trondelag. J Clin Epidemiol 2000;53:1150-7.
3. Herbison P, Hay-Smith J, Ellis G, Moore K. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ 2003;326:841-4. (Pubitemid 36461413)
4. van Ermengem E. Ueber einen neuen anaeroben Bacillus und seine Beziehungen zum Botulismus. Ztsch Hyg Infekt 1897;26:1-56.
5. Dolly JO. General properties and cellular mechanisms of neurotoxins. In: Jankovic J, Hallet M, editors. Therapy with botulinum toxin. New York: Marcel Dekker; 1994.
6. O'Brien CF. Treatment of spasticity with botulinum toxin. Clin J Pain 2002;18:182-90.
7. Schurch B, Stohrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injury patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 2000;164:692-7. (Pubitemid 30637604)
8. Schurch B, Schmid DM, Stohrer M. Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med 2000;342:665. (Pubitemid 30118430)
9. Reitz A, Stohrer M, Kramer G, Del Popolo G, Chartier-Kastler E, Pannek J, et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004;45:510-5. (Pubitemid 38376219)
10. Schäfer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 2002;21:261-74. (Pubitemid 34411846)
11. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. BJOG 1997;104:1374-9. (Pubitemid 27517634)
12. Reese PR, Pleil AM, Okano GJ, Kelleher CJ. Multinational study of reliability and validity of the King's Health Questionnaire in patients with overactive bladder. Qual Life Res 2003;12:427-42. (Pubitemid 36609887)
13. Loch A, Loch T, Osterhage J, Alloussi S, Stöckle M. Botulinum-A toxin detrusor injections in the treatment of non-neurologic and neurologic cases of urge incontinence. Eur Urol Suppl 2003;2:172 [abstract 678].
14. Zermann DH, Ishigooka M, Schubert J, Schmidt RA. Trigonum and bladder base injection of botulinumtoxin A (BTX) in patients with severe urgency-frequency-syndrome refractory to conservative medical treatment and electrical stimulation. Neurourol Urodyn 2001;20:412-3 [abstract 27].
15. Radziszewski P, Borkowski A. Botulinum toxin type A intravesical injections for instable bladder overactivity. Eur Urol Suppl 2002;1:134 [abstract 526].